|
There is a clinical trial for Herceptin for Stage 2 Her2/neu +++, but the trial involves AC and the taxenes. However, it is possible to get the drug "off-label," that is, not as part of the trial. If it is not part of a trial, because Herceptin is not yet standard for Stage 2 breast cancer, the insurance companies may object to covering the costs. However, this route is certainly worth investigating.
|